Senti Biosciences is trading 12.17% down at $0.19 after closing at $0.22 on October 29, 2026; no clear company-specific announcement explaining the after-hours decline was identified. - Recent coverage concerned a director’s resignation and the CVR distribution record date, not a new October 29 catalyst. - The Nasdaq fell 2.32% and the S&P 500 0.97%; risk-off sentiment may have contributed, but a direct link is unconfirmed. Available evidence is limited, and confidence is low.